Search

Your search keyword '"Bouwmans, Pim"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Bouwmans, Pim" Remove constraint Author: "Bouwmans, Pim"
31 results on '"Bouwmans, Pim"'

Search Results

2. Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control study

3. The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients

4. Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study

5. Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

6. #2681 Impact of sharing anti-SARS-CoV-2 antibody levels with Kidney Transplant Recipients on adherence to preventive measures and incidence of COVID-19

7. Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients

8. Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease:A nested case-control study

10. SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunity.

11. The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients

12. Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study

13. #3852 INCIDENCE AND SEVERITY OF COVID-19 IN RELATION TO ANTI-RBD IGG ANTIBODY LEVEL AFTER COVID-19 VACCINATION IN KIDNEY TRANSPLANT RECIPIENTS

14. #3738 KIDNEY TRANSPLANT RECIPIENTS BECOME LESS ADHERENT TO PREVENTIVE MEASURES AFTER SARS‑COV‑2 VACCINATION AND AFTER AWARENESS OF ANTIBODY RESPONSE

16. Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

17. Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands:a nationwide questionnaire study

18. Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy

19. Kidney Transplant Recipients Become Less Adherent to Preventive Measures after SARS‑CoV‑2 Vaccination and after Awareness of Antibody Response

20. Mycophenolic Acid Exposure Determines Antibody Formation Following SARS‐CoV‐2 Vaccination in Kidney Transplant Recipients: A Nested Cohort Study.

22. The Clinical Frailty Scale as a triage tool for ICU admission of dialysis patients with COVID-19: an ERACODA analysis.

23. The Clinical Frailty Scale as a triage tool for ICU admission of dialysis patients with COVID-19:an ERACODA analysis

25. MO337: Higher Antibody Response After 2 Vaccinations With MRNA-1273 as Compared With BNT162B2 and AZD1222 in High-Risk Kidney Patients

26. MO184: Development and Validation of a Multivariable Prediction Model for Nonseroconversion after SARS-COV-2 Vaccination in Kidney Transplant Recipients

27. The clinical frailty scale as a triage tool for ICU admission of dialysis patients with COVID-19 - An ERACODA analysis

28. Clinical Frailty Scale as a triage tool for ICU admission of dialysis patients with COVID-19: an ERACODA analysis.

29. Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients.

30. Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy.

31. The Clinical Frailty Scale as a triage tool for ICU admission of dialysis patients with COVID-19: an ERACODA analysis.

Catalog

Books, media, physical & digital resources